Advertisement

Related Videos

Russell Szmulewitz, MD, on Alternative Dosing of Abiraterone in Prostate Cancer: Pharmacoeconomic Proof of Concept

Mark Sculpher, PhD: How Do We Assess the Value of Cancer Drug Optimization?

Garth Strohbehn, MD, MPhil, on Applied Clinical Pharmacology in a Crisis: Interventional Pharmacoeconomics and COVID-19

Robin Feldman, JD: Are Dubious Patents a Large or Small Issue?

Matthew Seymour, MD: A Clinical Trialist’s Perspective

Advertisement

Advertisement




Feb
10
Today In Oncology
HPV Testing During Cervical Cancer Screening Potential Convenient and Noninvasive Method
Guidelines Harmonize Pan-Tumor Pathologic Response to Neoadjuvant Therapy
Tissue-Free ctDNA and Outcomes in Patients With Colorectal Cancer Receiving FOLFOX-Based Adjuvant Therapy
Ultraprocessed Food Associated With Increased Mortality Risk in Cancer Survivors
A Paradigm Shift In Treating Adult AML?
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo